Friday, February 26, 2021 10:25:29 AM
If we closed here at $0.54, the February monthly return would be +212.31%.
What ENZC accomplished in Fabulous February: Found immutable sites on HIV and COVID, filed international patents protecting these findings, announced partnership for producing mAbs with GenScript, announced trials scheduled to test these mAbs, announced the scanning of 14 other major viruses using AI to sequence and find immutable sites on those as well, released results showing ITV-1's broad efficacy and low toxicity, inked a new partnership (IMPL) with investors in Bulgaria that will fully fund clinical trials for ITV-1 to meet EMA standards (thus FDA approval fastrack), confirmed the long-anticipated plan to up-list to the OTCQB, updated their website, and are just a few weeks away from having audited financials.
Also worth mentioning that the +212.31% was during a period where most OTC runners got absolutely smoked to the tune of 20% per day for 2-weeks straight.
In my opinion, yeah, it was an impressive month and still deserving of the moniker.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM